Invesco Ltd. boosted its position in shares of Xometry, Inc. (NASDAQ:XMTR - Free Report) by 711.8% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 251,006 shares of the company's stock after buying an additional 220,088 shares during the quarter. Invesco Ltd. owned 0.51% of Xometry worth $10,708,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors and hedge funds also recently bought and sold shares of the company. Vanguard Group Inc. boosted its stake in Xometry by 2.1% during the fourth quarter. Vanguard Group Inc. now owns 4,293,272 shares of the company's stock worth $183,151,000 after buying an additional 86,997 shares during the period. Geode Capital Management LLC lifted its position in shares of Xometry by 0.9% during the fourth quarter. Geode Capital Management LLC now owns 1,004,452 shares of the company's stock worth $42,861,000 after purchasing an additional 8,974 shares during the last quarter. State Street Corp lifted its position in shares of Xometry by 0.3% during the third quarter. State Street Corp now owns 887,139 shares of the company's stock worth $16,297,000 after purchasing an additional 3,027 shares during the last quarter. Baillie Gifford & Co. bought a new stake in shares of Xometry during the fourth quarter worth $30,297,000. Finally, Charles Schwab Investment Management Inc. lifted its position in shares of Xometry by 3.2% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 366,156 shares of the company's stock worth $15,620,000 after purchasing an additional 11,307 shares during the last quarter. 97.31% of the stock is owned by hedge funds and other institutional investors.
Xometry Stock Up 6.4 %
Shares of XMTR stock traded up $1.62 during mid-day trading on Monday, hitting $26.78. 1,019,790 shares of the stock traded hands, compared to its average volume of 608,793. Xometry, Inc. has a 52-week low of $11.08 and a 52-week high of $45.33. The stock has a market cap of $1.35 billion, a P/E ratio of -25.50 and a beta of 0.72. The company has a debt-to-equity ratio of 0.90, a current ratio of 4.59 and a quick ratio of 4.55. The stock's fifty day moving average is $24.69 and its two-hundred day moving average is $29.76.
Insider Buying and Selling at Xometry
In other news, CEO Randolph Altschuler sold 27,566 shares of Xometry stock in a transaction on Friday, February 28th. The shares were sold at an average price of $26.60, for a total transaction of $733,255.60. Following the completion of the sale, the chief executive officer now directly owns 256,570 shares in the company, valued at approximately $6,824,762. The trade was a 9.70 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, COO Peter Goguen sold 3,000 shares of Xometry stock in a transaction on Tuesday, February 11th. The stock was sold at an average price of $35.57, for a total transaction of $106,710.00. Following the sale, the chief operating officer now owns 161,993 shares of the company's stock, valued at $5,762,091.01. The trade was a 1.82 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 78,256 shares of company stock worth $2,012,889 over the last three months. Corporate insiders own 16.79% of the company's stock.
Analyst Upgrades and Downgrades
XMTR has been the subject of several research analyst reports. JPMorgan Chase & Co. decreased their target price on Xometry from $45.00 to $30.00 and set an "overweight" rating for the company in a research report on Tuesday, April 22nd. Citigroup decreased their target price on Xometry from $46.00 to $39.00 and set a "buy" rating for the company in a research report on Thursday, February 27th. UBS Group lifted their target price on Xometry from $22.00 to $33.00 and gave the stock a "neutral" rating in a research report on Wednesday, February 26th. Cantor Fitzgerald lifted their target price on Xometry from $12.00 to $20.00 and gave the stock an "underweight" rating in a research report on Wednesday, February 26th. Finally, JMP Securities restated a "market outperform" rating and issued a $42.00 price objective on shares of Xometry in a report on Monday, February 10th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $34.44.
Read Our Latest Stock Analysis on XMTR
About Xometry
(
Free Report)
Xometry, Inc operates an online marketplace that enables buyers to source custom-manufactured parts and assemblies in the United States and internationally. It provides computer numerical control manufacturing, sheet metal forming, and sheet cutting; 3D printing, including fused deposition modeling, direct metal laser sintering, PolyJet, stereolithography, selective laser sintering, binder jetting, carbon digital light synthesis, multi jet fusion, and lubricant sublayer photo-curing; and die casting, stamping, injection molding, urethane casting, tube cutting, and tube bending, as well as finishing services, rapid prototyping, and high-volume production services.
Featured Articles

Before you consider Xometry, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xometry wasn't on the list.
While Xometry currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.